Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis

Abstract

Altogether, our results show that siponimod has neuroprotective effects in the CNS of EAE mice, which are likely independent of its peripheral immune effect, suggesting that this drug could be effective in limiting neurodegenerative pathological processes in MS.